(Q33329288)
Statements
A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer (English)
C F Verschraegen
E Gupta
E Loyer
J J Kavanagh
A P Kudelka
R S Freedman
C L Edwards
N Harris
M Steger
V Steltz
B C Giovanella